Хайлтын үр дүнгүүд - Eric J. Small

Үр дүнг сайжруулах
  1. 1
    Simultaneous antiandrogen withdrawal and treatment with ketoconazole and hydrocortisone in patients with advanced prostate carcinoma

    Simultaneous antiandrogen withdrawal and treatment with ketoconazole and hydrocortisone in patients with advanced prostate carcinoma -н Eric J. Small, Ari David Baron, Robert Bok

    Хэвлэсэн 1997
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  2. 2
    Malignant rhabdoid tumor of the heart in an infant

    Malignant rhabdoid tumor of the heart in an infant -н Eric J. Small, Beverly Barrett Dahms, Gregory J. Gordon

    Хэвлэсэн 1985
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  3. 3
    A phase II trial of cisplatin (C), gemcitabine (G) and gefitinib for advanced urothelial tract carcinoma: results of Cancer and Leukemia Group B (CALGB) 90102

    A phase II trial of cisplatin (C), gemcitabine (G) and gefitinib for advanced urothelial tract carcinoma: results of Cancer and Leukemia Group B (CALGB) 90102 -н George Philips, Susan Halabi, Ben L. Sanford, Dean F. Bajorin, Eric J. Small

    Хэвлэсэн 2009
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  4. 4
    Cancer and Leukemia Group B 90206

    Cancer and Leukemia Group B 90206 -н Brian I. Rini, Susan Halabi, John Taylor, Eric J. Small, Richard L. Schilsky

    Хэвлэсэн 2004
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  5. 5
    Germline and Somatic Mutations in Prostate Cancer for the Clinician

    Germline and Somatic Mutations in Prostate Cancer for the Clinician -н Heather H. Cheng, Alexandra Sokolova, Edward M. Schaeffer, Eric J. Small, Celestia S. Higano

    Хэвлэсэн 2019
    Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  6. 6
    Combination immunotherapy with prostatic acid phosphatase pulsed antigen‐presenting cells (provenge) plus bevacizumab in patients with serologic progression of prostate cancer after definitive local therapy

    Combination immunotherapy with prostatic acid phosphatase pulsed antigen‐presenting cells (provenge) plus bevacizumab in patients with serologic progression of prostate cancer afte... -н Brian I. Rini, Vivian Weinberg, Lawrence Fong, Shauna Conry, Robert M. Hershberg, Eric J. Small

    Хэвлэсэн 2006
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  7. 7
    Progression-Free Survival as a Predictor of Overall Survival in Men With Castrate-Resistant Prostate Cancer

    Progression-Free Survival as a Predictor of Overall Survival in Men With Castrate-Resistant Prostate Cancer -н Susan Halabi, Nicholas J. Vogelzang, San‐San Ou, Kouros Owzar, Laura Archer, Eric J. Small

    Хэвлэсэн 2009
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  8. 8
    Adrenal Androgen Levels as Predictors of Outcome in Prostate Cancer Patients Treated with Ketoconazole Plus Antiandrogen Withdrawal: Results from a Cancer and Leukemia Group B Study

    Adrenal Androgen Levels as Predictors of Outcome in Prostate Cancer Patients Treated with Ketoconazole Plus Antiandrogen Withdrawal: Results from a Cancer and Leukemia Group B Stud... -н Charles J. Ryan, Susan Halabi, San-San Ou, Nicholas J. Vogelzang, Philip W. Kantoff, Eric J. Small

    Хэвлэсэн 2007
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  9. 9
    A Phase II study of estramustine, docetaxel, and carboplatin with granulocyte–colony‐stimulating factor support in patients with hormone‐refractory prostate carcinoma

    A Phase II study of estramustine, docetaxel, and carboplatin with granulocyte–colony‐stimulating factor support in patients with hormone‐refractory prostate carcinoma -н William Oh, Susan Halabi, William Kevin Kelly, Cary Werner, Paul A. Godley, Nicholas J. Vogelzang, Eric J. Small

    Хэвлэсэн 2003
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  10. 10
    Diversity of Antigen-Specific Responses Induced In Vivo with CTLA-4 Blockade in Prostate Cancer Patients

    Diversity of Antigen-Specific Responses Induced In Vivo with CTLA-4 Blockade in Prostate Cancer Patients -н Serena S. Kwek, Vinh Dao, Ritu Roy, Yafei Hou, David Alajajian, Jeffrey P. Simko, Eric J. Small, Lawrence Fong

    Хэвлэсэн 2012
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  11. 11
    A randomized study comparing standard versus moderately high dose megestrol acetate for patients with advanced prostate carcinoma

    A randomized study comparing standard versus moderately high dose megestrol acetate for patients with advanced prostate carcinoma -н Nancy A. Dawson, Mark Conaway, Susan Halabi, Eric P. Winer, Eric J. Small, Diana Lake, Nicholas J. Vogelzang

    Хэвлэсэн 2000
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  12. 12
    The Prognostic Significance of Plasma Interleukin-6 Levels in Patients with Metastatic Hormone-Refractory Prostate Cancer: Results from Cancer and Leukemia Group B 9480

    The Prognostic Significance of Plasma Interleukin-6 Levels in Patients with Metastatic Hormone-Refractory Prostate Cancer: Results from Cancer and Leukemia Group B 9480 -н Daniel J. George, Susan Halabi, Timothy F. Shepard, Ben L. Sanford, Nicholas J. Vogelzang, Eric J. Small, Philip W. Kantoff

    Хэвлэсэн 2005
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  13. 13
    Prostate-Specific Antigen Changes As Surrogate for Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Second-Line Chemotherapy

    Prostate-Specific Antigen Changes As Surrogate for Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Second-Line Chemotherapy -н Susan Halabi, Andrew J. Armstrong, Oliver Sartor, Johann S. de Bono, Ellen B. Kaplan, Chen‐Yen Lin, Nicole Solomon, Eric J. Small

    Хэвлэсэн 2013
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  14. 14
    A phase 2 study of estramustine, docetaxel, and bevacizumab in men with castrate‐resistant prostate cancer

    A phase 2 study of estramustine, docetaxel, and bevacizumab in men with castrate‐resistant prostate cancer -н Joel Picus, Susan Halabi, William Kevin Kelly, Nicholas J. Vogelzang, Young E. Whang, Ellen B. Kaplan, Walter M. Stadler, Eric J. Small

    Хэвлэсэн 2010
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  15. 15
    A phase 1 study of everolimus and sorafenib for metastatic clear cell renal cell carcinoma

    A phase 1 study of everolimus and sorafenib for metastatic clear cell renal cell carcinoma -н Andrea Harzstark, Eric J. Small, Vivian Weinberg, Janine Sun, Charles J. Ryan, Amy Lin, Lawrence Fong, Dion R. Brocks, Jonathan E. Rosenberg

    Хэвлэсэн 2011
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  16. 16
    Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer

    Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer -н Susan Halabi, Chen‐Yen Lin, William K. Kelly, Karim Fizazi, Judd W. Moul, Ellen B. Kaplan, Michael J. Morris, Eric J. Small

    Хэвлэсэн 2014
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  17. 17
    Prospective Trial of the Herbal Supplement PC-SPES in Patients With Progressive Prostate Cancer

    Prospective Trial of the Herbal Supplement PC-SPES in Patients With Progressive Prostate Cancer -н Eric J. Small, Mark W. Frohlich, Robert Bok, Katsuto Shinohara, Gary D. Grossfeld, Zinovi Rozenblat, Wm. Kevin Kelly, Michele Corry, David Reese

    Хэвлэсэн 2000
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  18. 18
    CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion

    CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion -н Brian D. Kavanagh, Shaun O’Brien, David S. Lee, Yafei Hou, Vivian Weinberg, Brian I. Rini, James P. Allison, Eric J. Small, Lawrence Fong

    Хэвлэсэн 2008
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  19. 19
    Activity of second‐line chemotherapy in docetaxel‐refractory hormone‐refractory prostate cancer patients

    Activity of second‐line chemotherapy in docetaxel‐refractory hormone‐refractory prostate cancer patients -н Jonathan E. Rosenberg, Vivian Weinberg, William K. Kelly, M. Dror Michaelson, Maha Hussain, George Wilding, Mitchell E. Gross, Douglass Hutcheon, Eric J. Small

    Хэвлэсэн 2007
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  20. 20
    Preexisting Levels of CD4 T Cells Expressing PD-1 Are Related to Overall Survival in Prostate Cancer Patients Treated with Ipilimumab

    Preexisting Levels of CD4 T Cells Expressing PD-1 Are Related to Overall Survival in Prostate Cancer Patients Treated with Ipilimumab -н Serena S. Kwek, Jera Lewis, Li Zhang, Vivian Weinberg, Samantha K. Greaney, Andrea Harzstark, Amy Lin, Charles J. Ryan, Eric J. Small, Lawrence Fong

    Хэвлэсэн 2015
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:

Хайх хэрэгслүүд: